Latest filing published 28 Sept 2026 for 同和药业, €86k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 6 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +0.1%Entry CN¥7.09 · Close 08 Oct 2026 CN¥7.10
- +30.7%Entry CN¥12.05 · Close at T+365 CN¥15.75
- +34.9%Entry CN¥11.79 · Close at T+365 CN¥15.90
- +32.5%Entry CN¥11.94 · Close at T+365 CN¥15.82
- +44.9%Entry CN¥10.71 · Close at T+365 CN¥15.51
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
庞正伟: trading record in brief
庞正伟 is a declared insider of 同和药业 (chief executive), with filings sourced from SSE / SZSE (CSRC). The record holds 7 filings, for trades running from 9 September 2021 to 28 September 2026.
No open-market sale appears; the market trades are 7 purchases worth €3.0M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2026: 1 purchase and no sales on the market.
The median purchase comes to €436k. Clusters matter here: 1 out of 7 purchases overlapped with buying by a colleague within 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. Looking at 6 purchases old enough to measure, the stock rose over the following 90 days in 100% of cases; the median change was +19.1%. They describe history only and say nothing certain about the share price ahead.
On 28 September 2026 came the latest disclosure, an open-market purchase for €86k in 同和药业. Most trades are made public on the day they happen. That lag is the time during which only the insider knows about the trade. Every figure here comes from the filings published by SSE / SZSE (CSRC) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to 庞正伟
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 94,300 shares@ CN¥53.59432.9% of flowA股XSHESZSE:273000001605040100Canonical exit: 27 Dec 2026 (T+90)
- 118,000 shares9.9% of flowA股XSHESZSE:173000005146847070Canonical exit: 7 Mar 2022 (T+90)
- 240,320 shares20.4% of flowA股XSHESZSE:173000005142443650Canonical exit: 6 Mar 2022 (T+90)
- 360,000 shares30.6% of flowA股XSHESZSE:173000005130234340Canonical exit: 2 Mar 2022 (T+90)
- 39,500 shares2.9% of flowA股XSHESZSE:173000005038892640Canonical exit: 1 Feb 2022 (T+90)
- 300,000 shares21.3% of flowA股XSHESZSE:173000004818779360Canonical exit: 9 Dec 2021 (T+90)
- 200,000 shares14.8% of flowA股XSHESZSE:173000004799263680Canonical exit: 8 Dec 2021 (T+90)
7 of 7 declarations